News
Executive Change
30 Dec 2025
Biotech’s groove is back for 2026 as XBI surges on M&A and lower rates
Acquisition
Study finds anti-cholesterol drugs may reduce risk of death in diabetes patients
New Horizon expands wound care portfolio with Applied Tissue acquisition
Acquisition
30 Dec 2025
IPO
30 Dec 2025
Phase 3Clinical ResultPhase 2Phase 1Drug Approval
30 Dec 2025
Phase 2Drug ApprovalPriority ReviewNDAImmunotherapy
30 Dec 2025
30 Dec 2025
Phase 2
Explore drug data on our website after registering.
synapse.patsnap.com
Copy